CAH three-lens brief
Evidence-based stock research on CAH. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 26.7pp over 30 days. · RSI at 28 — technically oversold.
- RSI at 28 — technically oversold.
- Underperforming SPY by 26.7pp over 30 days.
- Analyst mean target $245.27 — 34% above current (15 analysts).
CAH closed at $183.08 (+0.28%) as of 2026-05-13. Market cap: $42.88B. P/E (trailing) 28.0. Positives: analyst mean target $245.27 — 34% above current (15 analysts).. Concerns: rSI at 28 — technically oversold.; underperforming SPY by 26.7pp over 30 days.. Last quarter: Revenue $60.94B, net income $399.00M, free cash flow $4.85B.
Why three lenses on CAH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CAHacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CAH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CAH brief"></iframe>